AU2001234089A1 - Cancer remedy comprising anthranilic acid derivative as active ingredient - Google Patents

Cancer remedy comprising anthranilic acid derivative as active ingredient

Info

Publication number: AU2001234089A1
Authority: AU; Australia
Prior art keywords: active ingredient; acid derivative; anthranilic acid; cancer remedy; remedy
Prior art date: 2000-02-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001234089A

Other versions

AU2001234089B2 (en

Inventor

Takashi Kawamura

Takumi Takeyasu

Naoki Tsuchiya

Takashi Tsuruo

Takao Yamori

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Teijin Ltd

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-15

Filing date

2001-02-15

Publication date

2001-11-08

2001-02-15 Application filed by Teijin Ltd filed Critical Teijin Ltd

2001-02-15 Priority claimed from PCT/JP2001/001090 external-priority patent/WO2001060354A1/en

2001-11-08 Publication of AU2001234089A1 publication Critical patent/AU2001234089A1/en

2005-08-11 Application granted granted Critical

2005-08-11 Publication of AU2001234089B2 publication Critical patent/AU2001234089B2/en

2021-02-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001234089A 2000-02-15 2001-02-15 Cancer remedy comprising anthranilic acid derivative as active ingredient Ceased AU2001234089B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000036386		2000-02-15
JP2000-36386		2000-02-15
PCT/JP2001/001090 WO2001060354A1 (en)	2000-02-15	2001-02-15	Cancer remedy comprising anthranilic acid derivative as active ingredient

Publications (2)

Publication Number	Publication Date
AU2001234089A1 true AU2001234089A1 (en)	2001-11-08
AU2001234089B2 AU2001234089B2 (en)	2005-08-11

Family

ID=18560433

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU3408901A Pending AU3408901A (en)	2000-02-15	2001-02-15	Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2001234089A Ceased AU2001234089B2 (en)	2000-02-15	2001-02-15	Cancer remedy comprising anthranilic acid derivative as active ingredient

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU3408901A Pending AU3408901A (en)	2000-02-15	2001-02-15	Cancer remedy comprising anthranilic acid derivative as active ingredient

Country Status (5)

Country	Link
US (2)	US20030220402A1 (en)
EP (1)	EP1256341A4 (en)
AU (2)	AU3408901A (en)
CA (1)	CA2400264A1 (en)
WO (1)	WO2001060354A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003024448A2 (en)	2001-09-14	2003-03-27	Methylgene, Inc.	Inhibitors of histone deacetylase
US7868204B2 (en)	2001-09-14	2011-01-11	Methylgene Inc.	Inhibitors of histone deacetylase
US6897220B2 (en)	2001-09-14	2005-05-24	Methylgene, Inc.	Inhibitors of histone deacetylase
GB0319124D0 (en) *	2003-08-14	2003-09-17	Smithkline Beecham Corp	Chemical compounds
WO2005030704A1 (en)	2003-09-24	2005-04-07	Methylgene, Inc.	Inhibitors of histone deacetylase
KR100557093B1 (en) *	2003-10-07	2006-03-03	한미약품 주식회사	Tetrazole derivatives having multi-drug resistance inhibitory activity and preparation method thereof
US7253204B2 (en)	2004-03-26	2007-08-07	Methylgene Inc.	Inhibitors of histone deacetylase
JP5319113B2 (en) *	2004-03-26	2013-10-16	メチルジーンインコーポレイテッド	Inhibitors of histone deacetylase
WO2006014012A2 (en)	2004-08-06	2006-02-09	Otsuka Pharmaceutical Co., Ltd.	Aromatic compounds
BRPI0611784A2 (en) *	2005-06-14	2010-09-28	Hoffmann La Roche	compounds, process for their manufacture, pharmaceutical compositions comprising them and use of such compounds
CA2623759A1 (en) *	2005-10-06	2007-04-19	Exelixis, Inc.	Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
EP1957073B1 (en) *	2005-12-05	2014-04-23	Otsuka Pharmaceutical Co., Ltd.	Medicinal drug
CN101466670B (en)	2006-04-07	2013-04-17	梅特希尔基因公司	Inhibitors of histone deacetylase
UA95978C2 (en)	2006-10-02	2011-09-26	Оцука Фармас'Ютікел Ко., Лтд.	Stat3/5 activation inhibitor
GB0725214D0 (en) *	2007-12-24	2008-02-06	Karobio Ab	Pharmaceutical compounds
WO2015026990A2 (en) *	2013-08-20	2015-02-26	University Of Washington Through Its Center For Commercialization	Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydrolase
MX2021011209A (en) *	2019-03-15	2022-01-19	Massachusetts Gen Hospital	Novel small molecule inhibitors of tead transcription factors.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2934543A1 (en) *	1979-08-27	1981-04-02	Basf Ag, 6700 Ludwigshafen	SUBSTITUTED N-BENZOYLANTHRANILE ACID DERIVATIVES AND THEIR ANYDRO COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS HERBICIDES
US5705521A (en) *	1990-02-12	1998-01-06	The Center For Innovative Technology	Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
GB9022785D0 (en) *	1990-10-19	1990-12-05	Merck Sharp & Dohme	Therapeutic agents
JPH05301838A (en) *	1991-10-15	1993-11-16	Mitsubishi Kasei Corp	Styrene derivative
US5945450A (en) *	1994-05-31	1999-08-31	Teijin Limited	Naphthalene derivative
US5808144A (en) *	1995-11-27	1998-09-15	Teijin Limited	Benzene derivatives
CA2337098C (en) *	1998-07-24	2008-08-05	Teijin Limited	Anthranilic acid derivatives

2001
- 2001-02-15 US US10/203,288 patent/US20030220402A1/en not_active Abandoned
- 2001-02-15 EP EP01906131A patent/EP1256341A4/en not_active Withdrawn
- 2001-02-15 WO PCT/JP2001/001090 patent/WO2001060354A1/en not_active Ceased
- 2001-02-15 AU AU3408901A patent/AU3408901A/en active Pending
- 2001-02-15 AU AU2001234089A patent/AU2001234089B2/en not_active Ceased
- 2001-02-15 CA CA002400264A patent/CA2400264A1/en not_active Abandoned
2004
- 2004-08-24 US US10/923,875 patent/US20050027008A1/en not_active Abandoned

Similar Documents

Publication	Publication Date	Title
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001269529A1 (en)	2002-01-30	Medicine comprising dicyanopyridine derivative
EP1461044A4 (en)	2007-06-13	Pharmaceutical compositions comprising active vitamin d compounds
AU2002342968A1 (en)	2003-06-19	Fatty acid compounds, preparation and uses thereof
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001234089A1 (en)	2001-11-08	Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU3408901A (en)	2001-08-27	Cancer remedy comprising anthranilic acid derivative as active ingredient
AU2002257582A1 (en)	2002-09-04	Pharmaceutical formulation
AU2001289102A1 (en)	2002-03-26	Topical formulations for delivery of interleukin-11
AU2001248943A1 (en)	2001-10-30	Pharmaceutical curative compound
AU2001283344A1 (en)	2002-02-25	Dermatological formulation
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001244671A1 (en)	2001-12-20	Quinolonecarboxylic acid derivative
AU2002350942A1 (en)	2003-06-30	Imidazolidineacetic acid derivatives
AU2001235437A1 (en)	2001-08-07	Isothiazolecarboxylic acid derivatives and their use as microbicides
AU2002315848A1 (en)	2003-06-19	Remedies for eosinophilic diseases
AUPQ365299A0 (en)	1999-11-18	Anthranilic acid derivatives
AU2001260089A1 (en)	2001-12-03	Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2001293697A1 (en)	2002-02-05	N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AUPQ851000A0 (en)	2000-07-27	Rapid fatty acid delivery
AU2001274231A1 (en)	2001-12-24	Novel aqueous anti-inflammatory pharmaceutical formulation
AU2001264129A1 (en)	2001-12-24	Novel aqueous anti-inflammatory pharmaceutical formulation
AU2002218527A1 (en)	2002-06-18	Ocular tension-lowering compositions for topical administration
AU2002315287A1 (en)	2002-10-28	Pharmaceutical composition comprising clavulanic acid